Comparative Efficacy and Safety of PD-1/PD-L1 Inhibitors for Patients with Solid Tumors: A Systematic Review and Bayesian Network Meta-analysis

Purpose: The clinical use of immunotherapies targeting programmed death 1 (PD-1)/programmed death ligand 1 (PD-L1) is rapid expanding, but the equivalency of these inhibitors remains unclear. We aimed to comprehensively compare the efficacy and safety of PD-1/PD-L1 inhibitors with a systematic revie...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Cancer
Autores principales: Huang, Qingyuan, Zheng, Yuzhen, Gao, Zhendong, Yuan, Lianxiong, Sun, Yihua, Chen, Haiquan
Formato: Artigo
Lenguaje:Inglês
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7797652/
https://ncbi.nlm.nih.gov/pubmed/33442411
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.49325
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares